AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2021
Aug 25, 2021
30016_dirs_2021-08-25_78dbe060-04be-4bb1-9ac6-ab48ee088426.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-08-23
Reporting Person: POLEWACZYK JAMES F (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-23 | Common Stock | G | 522 | — | Disposed | 19494.2845 | Direct |
Footnotes
F1: Includes 11.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13